reduce basal insulin when starting glp-1 receptor agonist Combination of and agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes? | Diabetology & Metabolic Syndrome Glucagon-like peptide-1 receptor: mechanisms and

Analysis of serious weight gain in patients using alectinib for ALK positive lung cancer, semaglutide a potential treatment for serious weight gain from ALK tyrosine kinase inhibitors

Rights and permissions About this article Cite this article van der Aart-van der Beek, A.B., Heerspink, H.J.L

Forest plot of GLP-1 receptor agonists versus comparators on the risk of pneumonia

\mathrm{size \) after filtering on availability of weight measurements and prescription and/or BS)

Among people with no prior substance use disorder, those taking GLP-1 drugs had an 18% lower risk of developing alcohol use disorder, a 25% lower risk of opioid use disorder and an approximately 20% lower risk of cocaine and nicotine dependence

Large meals, greasy foods, fried foods, very rich meals, alcohol, carbonated drinks, and heavy late-night eating may sit in the stomach longer and trigger nausea, reflux, burping, or vomiting